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ABSTRACT:  It has been postulated that serial inhomogeneity of ventilation in the
peripheral airways in emphysema is represented by the shape of expiratory carbon
dioxide tension versus volume curve.  We examined the diagnostic value of this test
in patients with various degrees of emphysema.
The volumes between 25–50% (V25–50) and 25–75% (V25–75) of the expiratory
carbon dioxide tension versus volume curve were determined in 29 emphysematous
patients (20 severely obstructed and 9 moderately obstructed), 12 asthma patients
in exacerbation of symptoms, and 28 healthy controls.   Discriminant analysis was
used to examine whether these diagnostic groups could be separated.
With regard to phase 2 of the expiratory CO2 versus volume curve (mixture of
anatomic deadspace and alveolar air), a plot of intercept versus slope of the relation-
ships of (V25–50) and (V25–75) versus inspiratory volume (VI) from functional residual
capacity (FRC), obtained during natural breathing frequency, proved to be most
discriminating in the separation between healthy controls and severely obstructed
emphysema patients.  Separating healthy controls and severely obstructed emphyse-
ma pat- ients on the basis of the discriminant line for V25–50, 9 of the 12 asthma patients
in exacerbation were classified as normal, and only 5 of the 9 moderately obstructed
emphysema patients as emphysematous.   For V25–75 involvement of phase 3 of the
curve (alveolar plateau) in asthma patients in exacerbation caused a marked overlap
with the severely obstructed emphysema patients.  In the healthy controls, a fixed
breathing frequency of 20 breaths·min-1 led to an increase of both volumes.  For V25–50,
this resulted in an overlap with the severely obstructed emphysematous patients. 
We conclude that V25–50 and V25–75 are not useful in the diagnosis of emphyse-
ma.  This indicates that the ventilatory inhomogeneity as reflected by Phase 2 of
the expiratory carbon dioxide tension versus volume curve is not sensitive enough
for diagnostic application.
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During expiratory capnography 3 phases can be observed:
phase 1 with air from the anatomic deadspace of the air-
ways without CO2, followed by phase 2 showing a rapid
rise in CO2, leading to phase 3:  the alveolar plateau.
The abnormal shape of the expiratory carbon dioxide ten-
sion (PCO2) versus time curve in emphysema patients has
often been studied [1–5] and has been attributed to ser-
ial, as well as parallel, inhomogenity of ventilation.  The
time between 25–75% of the end-tidal PCO2 [4], and the
minimum radius of curvature [5], resulted in abnormal-
ly high values in emphysema patients compared to asth-
ma patients and healthy controls.  The dependence of the
expiratory PCO2 versus time curve on expiratory flow has
led to the use of the PCO2 versus volume curve [6–8].
WORTH [7, 8] focused on phase 2, and determined the
volume expired between 25–50% (V25–50), and 25–75%
(V25–75) of the inspiratory to end-tidal partial pressure
differences for He, SF6, O2 and CO2.  He found that the
slopes of the relationships between V25–50 or V25–75 and
inspiratory volume (VI) for these gases increased more
in emphysema than in healthy controls and asthma patients,
which he explained on basis of serial ventilatory inho-
mogeneity due to a different airway morphology.
The aim of the present study was to further evaluate
the diagnostic value of V25–50(CO2) and V25–75(CO2) ver-
sus VI by comparing at first severely obstructed emphy-
sema patients with healthy controls (as has been done in
earlier studies), and subsequently, on basis of the former
results, investigating whether emphysema patients with
less airway obstruction could be separated from healthy
controls, and whether asthma patients in exacerbation
could be distinguished from emphysema patients.
Moreover, we investigated the influence of breathing
pattern on V25–50 and V25–75 in the first 10 severely
obstructed emphysema patients and healthy controls who
entered the study.  Breathing pattern was characterized
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by inspiratory volume (VI), expiratory volume (VE) inspi-
ratory time (TI), expiratory time (TE) mean inspiratory
and expiratory flow (VI/TI and VE/TE), and end-tidal
PCO2 (PET,CO2), respectively.  The relationship of V25–50
and V25–75 at a fixed inspiratory volume of 1 l with
height, and the influence of a fixed breathing frequen-
cy, was evaluated in all healthy controls.
Methods
Study population
The healthy controls were 28 persons with no history
of disease from cardiopulmonary origin.  The patient
group consisted of 12 asthma patients in exacerbation of
symptoms and 29 emphysema patients, 20 of the latter
being severely obstructed (forced expiratory volume in
one second (FEV1) values below 1.4 l ) and 9 moderately
obstructed.  In 5 of the asthma patients, the investigations
were repeated after recovery.  Mean values for anthro-
pometric data, including age, sex, length and body mass
index (BMI: weight in kg/length in m2) are reported in
table 1.  The controls had a relatively high weight and
normal spirometric values, although residual volume (RV)
and functional residual capacity (FRC) values were rela-
tively low.  The asthma patients, however, were younger
and mostly female.  The moderately obstructed emphy-
sema patients were comparable in age and weight with
the severely obstructed emphysema patients, but had bet-
ter FEV1 values, which were in the same range as those
of the exacerbation asthma patients.   The severely obst-
ructed emphysema patients were mostly men, character-
ized by a relatively low body weight, reflected by their
BMI.  They had severe obstruction and hyperinflation.
Both groups of emphysema patients showed only slight
and comparable improvement after bronchodilator inhala-
tion (0.75 mg terbutaline by metered-dose inhaler (MDI).
Mean improvements in % of initial FEV1 were 6.1% (SD
5.5%) and 5.9% (SD 6.7%) for the severely and moder-
ately obstructed emphysema patients, respectively.  Blood
gas values indicated primarily hypoxaemia, without an
overall alveolar hypoventilation.
Clinical diagnosis
For the diagnosis of emphysema the American Thora-
cic Society (ATS) criteria for chronic obstructive pul-
monary disease (COPD) [9] and the X-ray criteria
described by PRATT [10] were used: the latter are based
on signs of hyperinflation and tissue loss on the pos-
teroanterior and lateral chest X-ray.  On the posteroan-
terior X-ray two signs may be present: 1) depression
and flattening of the diaphragm with blunting of
costophrenic angles;  and 2) irregular radiolucency of
lung fields.  On the lateral X-ray there are also two
signs: 1) abnormal retrosternal space; and 2) flattening,
or even concavity, of the diaphragm.  Emphysema was
diagnosed if two or more of these criteria were present.
Asthma was diagnosed according to the ATS criteria:
a clinical syndrome characterized by increased respon-
siveness of the tracheobronchial tree to a variety of
stimuli, with symptoms of paroxysmal dyspnoea, wheez-
ing and cough,  and, as a physiological manifestation
of this hyperresponsiveness, variable airways obstruc-
tion [9].  Only those patients in whom the airways
obstruction was completely reversible after recovery
were selected for this study.
All healthy controls older than 50 yrs underwent chest
X-ray to exclude pulmonary pathology.
Pulmonary function tests
Pulmonary function tests in the patient group includ-
ed spirometry, with estimation of total lung capacity
TLC, FRC, RV, vital capacity (VC), and FEV1. FRC
was estimated using the closed circuit helium dilution
method.  Arterial blood gas analysis was performed in
all severely obstructed patients in a stable phase.  Mean
values (and SD) of the pulmonary function variables are
presented in table 1.  Reference values for spirometry
were European Community for Coal and Steel  (ECCS)
values [11].
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Table 1.  –  Characteristics of subject groups
Healthy controls Exacerbation Moderately obstructed  Severely obstructed 
asthma patients emphysema patients emphysema patients
M/F  n 17/11 4/8 7/2 18/2
Age  yrs 51 (17) 36 (14)* 54 (10) 60 (12)
Height m 1.72 (0.10) 1.72 (0.13) 1.78 (0.08) 1.73 (0.08)
BMI kg·m-2 24.8 (2.7) 23.7 (2.9) 21.7 (2.9)* 21.1 (3.5)*
TLC % pred 102 (8) 103 (11) 132 (15)* 123 (11)*
FRC/TLC % pred 88 (12) 101 (15)* 118 (9)* 126 (14)*
RV/TLC % pred 87 (6) 101 (22)* 138 (22)* 150 (34)*
VC % pred 114 (13) 89 (18)* 106 (13) 87 (16)*
FEV1 % pred 106 (11) 57 (17)* 61 (12)* 29 (11)*
FEV1/VC % pred 74 (7) 53 (9)* 44 (6)* 25 (7)*
PaO2 kPa 8.8 (0.9)
Paco2 kPa  5.6 (0.7)
Data are presented as mean, and SD in parenthesis.  M: male; F: female; BMI: body mass index; TLC: total lung capacity; FRC:
functional residual capacity; RV: residual volume; FEV1: forced expiratory volume in one second; PaO2: arterial oxygen tension;
PaCO2: arterial carbon dioxide tension.
Measuring equipment 
The measuring equipment consisted of a CO2 analyser(Hewlett Packard, 47210A capnometer) in series with a
pneumotachometer head (Jaeger, Würzburg, Germany)
connected to a Validyne transducer, model P46 (Validyne
Corp., Northridge, CA, USA).  A pneumotachometer was
used in view of its dynamic properties, thus avoiding dis-
tortion of phase 2 and synchronization difficulties, which
are to be expected when a spirometer system is used.  Both
signals, PCO2 and flow, were sampled with a frequency of
50 Hz and analysed by the lung function computer net-
work at our laboratory [12].  Flow was integrated to vol-
ume.  A time delay, inherent to the capnograph, of 160
ms was needed to synchronize the CO2 signal with the
flow signal.  The pneumotachometer head was maintained
at a constant temperature of 37°C.  As the humidity and
temperature of the gas in the pneumotachometer head are
difficult to estimate, a humidity of 50% and a mean tem-
perature of 30°C were assumed.  From these values and
the current barometric pressure a body temperature and
pressure saturated with water vapour (BTPS) correction was
made for the inspired air.  For the expiratory gas, BTPS
conditions were present.  Before each measurement, cal-
ibration with a 1 l syringe was carried out.
Because volume integration was performed over a rel-
atively large number of breaths in series, a correction had
to be made for volume drift.  Assuming an unchanged
RV during the test, a correction factor was established
based on RV level after maximal expiration at  the begin-
ning and end of the procedure (fig. 1).  The accuracy of
the volume estimation was verified with a spirometer in
series.  The volume measured by the pneumotachometer
was slightly (but randomly) different from the volume
measured by the spirometer, and within a range of about
5%.
The dead space volume of mouthpiece, CO2 analyser
and pneumotachometer head was 50 ml.
Experimental protocol
Each test consisted of a series of 40–80 consecutive
breaths with natural breathing frequency.  With inter-
vals of 3–5 normal breaths, the subject took a voluntary
deep breath from FRC, returning to FRC (fig. 1).  The
controls repeated these manoeuvres at fixed frequencies
of 10, 15 and 20 breaths·min-1.  For each breath the fol-
lowing characteristics were determined: TI, TE, VI, VE,
and PET,CO2.
An expiratory PCO2/VE curve was plotted (fig. 2).
Variables derived from this curve were: 1) V25–50: the vol-
ume expired between 25–50% of the PET,CO2; and 2) V25–75:
the volume expired between 25–75% of the PET,CO2.
Analysis of the variables was performed on all breaths
starting at FRC level.  A breath was rejected if the dif-
ference between inspiratory and expiratory volume exceed-
ed 300 ml, or if inspiratory or expiratory volume was
less than 300 ml.
Statistical methods
Linear regression analysis was used to determine the
linear relationship and correlation coefficient (r) of V25–50
and V25–75 with VI and the other breath characteristics.
Multiple linear regression analysis was used to investi-
gate whether a second breath characteristic (the first being
VI) could improve the linear relationships (expressed as
r2, the coefficient of determination).  Discriminant analy-
sis was applied to investigate whether two groups could
be separated on the basis of intercept and slope of the
linear relationships.  Unpaired and paired t-tests were
applied to detect differences between and within groups,
respectively.
For statistical analysis, the commercial computer pro-
grams Statgraphics and Statistical Package for the Social
Sciences (SPSS) were used.
Results
V25–50 and V25–75 versus VI in the study groups
Examples of the relationship between V25–50 and VI,
and V25–75 and VI with their regression lines for a healthy
control and severely obstructed emphysema patient are
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Fig. 1.  –  Example of a recording of volume vs time and carbon diox-
ide tension (PCO2) vs  time. A: represents extent of baseline drift (ml)
over time (B).
Fig. 2.  –  Variables V25–50 and V25–75 derived from the expiratory
PCO2 vs volume curve.  V25–50 and V25–75: volume expired between
25–50% and 25–75% of the PET,CO2, respectively; PET,CO2: end-tidal
carbon dioxide tension.
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Fig. 3.  –  a) Examples of V25–50 vs VI with regression lines, in one
severely obstructed emphysematous patient and one healthy control.
❒ : severly obstructed emphysema patient;  + : healthy control;                :
linear regression lines for both groups.  b) Slope vs intercept of linear
regression lines of V25–50 vs VI in 20 severely obstructed emphysema
patients and 28 healthy controls. ❑ : severely obstructed emphysema
patient; + : healthy control;              : discriminant line.  c) Slope
vs   intercept of linear regression lines of V25–50 vs VI in 9 moder-
ately obstructed emphysema patients (❒); in 12 exacerbation asthma
patients ();  and in 5 asthma patiens after recovery (   ).            :
discriminant line from 3b. VI:  inspiratory volume.  For further abbre-
viations see legend to figure 2.
Fig. 4.  –  a) Examples of V25–75 vs VI with regression lines in one
severely obstructed emphysema patient and one healthy control; ❒ :
severely obstructed emphysema patient;  + : healthy control;            :
linear regression lines for both groups.  b) Intercept vs slope of linear
regression lines of V25–75 vs VI in 20 severely obstructed emphysema
patients and 28 healthy controls; ❑ : severely obstructed emphysema
patient; +: healthy control;             : discriminant line.  c) Slope vs
intercept of linear regression lines of V25–75 in 9 moderately obstruct-
ed emphysema patients (❒); in 12 exacerbation asthma patients ();
and in 5 asthma patients after recovery (  ).            : discriminant
line from 4b.  For abbreviations see legend to figures 2 and 3.
shown in figures 3a and 4a, respectively.  The X-Y-plots
of intercept versus slope of the individual regression
lines of all healthy controls and severely obstructed
emphysema patients showed that the two groups had only
a slight overlap (figs 3b and 4b).  Discriminant lines
(determined by discriminant analysis) are drawn in these
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relation coefficients (r) were in the range 0.80–0.90 with
a mean SD of 0.10.  However, multiple regression analy-
sis did not show an appreciable increase of r2 or reduc-
tion of residual variance when either of the other
characteristics (TI, TE, VE, VI/TI, VE/TE or PET,CO2) was
added as a second variable (the first being VI).
In the 10 severely obstructed emphysema patients,
V25–50 and V25–75 were significantly correlated with VI
in eight cases, two patients showing no significant cor-
relation with r<0.30.  This was why the mean correla-
tion coefficients were lower, with values of 0.59 (SD 0.28)
and 0.73 (SD 0.30) for V25–50 and V25–75, respectively.
Because, in the two patients mentioned above, a signi-
ficant correlation of V25–50 existed only with TI and VI/TI,
a multiple regression analysis adding these variables,
increased r2.  At a fixed inspiratory volume of 1 l, there
was a positive correlation of V25–50 and V25–75 with height
in the 28 controls, with correlation coefficients of 0.56
(p=0.002) and 0.43 (p=0.022), respectively.
Discussion
This study was aimed at determining the diagnostic
value of phase 2 indices of the PCO2 versus volume curve
in pulmonary emphysema.  The results showed that severe-
ly obstructed emphysema patients could be separated
from healthy controls and asthma patients after recov-
ery on the basis of a plot of intercept versus slope of
the relationships of V25–50 or V25–75 versus VI.  Separa-
tion of asthma patients in exacerbation and severely
obstructed emphysema patients was only possible for the
relationship of V25–50 versus VI.  Moderately obstructed
emphysema patients showed a marked overlap with healthy
controls; and increasing breathing frequency in hea-
lthy controls caused an overlap with the severely obstruct-
ed emphysema patients for the relationship of V25–50
versus VI.  Finally, in healthy controls both V25–50  and
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figures.  These lines yielded a sensitivity of 80–90% for
both volume indices, and a specificity of 89% for V25–50
versus VI and 100% for V25–75 versus VI relationship.
In figures 3c and 4c, the discriminant lines separat-
ing healthy controls and severely obstructed emphyse-
ma patients were drawn (taken from 3b and 4b), together
with plots of intercept and slope of the regression lines
for the asthma patients in exacerbation and the moder-
ately obstructed emphysema patients.  In figure 3c the
symbols, representing intercept and slope of the regres-
sion lines for the asthma patients in exacerbation were
predominantly on the "control" side of the discriminant
line.  In the case of V25–75 vs VI there was more over-
lap with the emphysema patients, which disappeared
after recovery in 2 of the 5 asthma patients, who repeat-
ed the test after recovery (fig 4c).  Only 5 of the 9 mod-
erately obstructed emphysema patients were located on
the emphysema side of the discriminant lines.
Influence of breathing frequency in the controls
Fixed breathing frequencies of 10, 15 and 20 breaths· min-1
in the healthy controls generally showed an increase of
V25–50 and V25–75 in relation to VI with increase of breath-
ing frequency (figs 5 and 6).  At a breathing frequency
of 20 breaths·min-1 the position of intercepts and slopes
of the regression lines of V25–50 showed a marked over-
lap with those of the severely obstructed emphysema
patients.
Influence of breath characteristics and height
In the 10 controls, in all cases V25–50 and V25–75 were
significantly correlated with VI, but also with VE, VI/TI
and VE/TE, the last variables representing mean inspi-
ratory and mean expiratory flow, respectively.  The cor-
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Fig. 5.  –  Slope versus intercept of linear regression lines of V25–50
vs VI in 28 healthy controls with different breathing frequencies.  :
10 breaths· min-1;  + : 15 breaths·min-1;     : 20 breaths·min-1;                   :
discriminant line as in figure 3b.
Fig. 6.  –  Slope versus intercept of linear regression lines of V25–75
vs VI in 28 healthy controls with different breathing frequencies.  :
10 breaths·min-1;  + : 15 breaths·min-1;     : 20 breaths·min-1;               :
discriminant line as in figure 4b.  For abbreviations see legnd to fig-
ures 2 and 3.
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V25–75 showed a positive correlation with height at an
inspiratory volume of 1 l.
Our clinical diagnosis of emphysema may be subject
to criticism.  Emphysema is histologically diagnosed [9],
and diagnosis of this disease is often difficult in its early
stage.   Use of computed tomography (CT) [13–15] and,
more recently, high resolution CT [16–19], with esti-
mation of density, is currently the gold standard.  These
techniques enable the disease to be diagnosed at an ear-
lier stage, but are costly and no standardized procedure
has yet been established [20].  Characteristic chest X-
ray abnormalities usually develop in a later stage of the
disease [21].  Diagnostic chest X-ray criteria related to
histological findings were described by PRATT [10] in
1987, who claimed good sensitivity and specificity.
Although chest X-ray signs were not detected in some
emphysema patients in his study, this is a well-known
disadvantage of the chest X-ray [20]; X-ray signs were
never positive in normal lungs, and positive signs of
emphysema always coincided with histologically proven
emphysema.  The positive predictive value can, thus, be
considered as 100%; and this has never been disproved
by the new gold standard, the high resolution CT scan.
Although increased lung compliance and reduced pul-
monary diffusion capacity are considered to be the most
indicative pulmonary function indices for emphysema
[22–25], they were not performed in all patients for tech-
nical reasons (single-breath diffusion capacity test requires
a minimum FEV1 of 1 l) and due to burdening of the
patients (compliance).
Since a late stage of the disease is accompanied by
severe airways obstruction, chest X-ray and FEV1 were
chosen to characterize the patients and, thus, defined the
severely obstructed emphysema group. Some patients,
however, were clearly less obstructed and were separat-
ed at the beginning of the study to serve as a second
emphysema group, with moderate emphysema.  As air-
ways obstruction also occurs in asthma patients, our sec-
ond check on the validity of the test as a diagnostic test
for emphysema was made using this group of asthmat-
ics with exacerbation of symptoms.  They had normal
FEV1 and VC values after recovery, with no signs of
emphysema on chest X-ray, and were considered to have
no emphysema.
For the alveolar plateau of the capnograph, it is gen-
erally accepted that primarily parallel ventilation-perfu-
sion inhomogeneity, in combination with sequential
emptying of the lung units, defines its value, slightly
modified by the ongoing CO2 excretion [6].  The alveo-
lar plateau slope values and PET,CO2 undoubtedly influ-
ence the magnitude of V25–50 and V25–75, which means
that these mechanisms also contribute to the values.
WORTH [7, 8] postulated that serial inhomogeneity
in a trumpet model was the main determining mecha-
nism.  Thus, increased serial inhomogeneity due to morph-
ological changes in peripheral airways in emphysema
patients provides an explanation for the increase both of
V25–50 and V25–75; and, moreover, for the increase of these
variables with increasing VI.  The findings of WORTH [7,
8] have been extended in the present study by enlarging
the number of patients, and using not only the change
with VI, but both the intercept and slope of the rela-
tionships.
For the discrimination of severely obstructed emphy-
sema patients and controls it appeared from our data that
a plot of slope versus intercept of the relationship of
either V25–50 or V25–75 versus VI gave most discrimina-
tion, if compared with the slope alone (fig. 3b and 4b).
Both for the V25–50 and V25–75 versus VI relationships,
we found on average a twofold smaller increase in slope
in emphysema patients compared to controls than WORTH
[7, 8].  The differences between our results and those of
WORTH [7, 8] could be due to difference in study popu-
lations, our study group being three times larger and,
moreover, age-matched with the controls, which was not
the case in Worth's study.
The results in the nine moderately obstructed emphy-
sema patients did not support the discriminatory value
of slope and intercept, and the asthma patients in exac-
erbation were only classified properly for the V25–50 ver-
sus VI relationship.  If morphological lesions alone were
responsible for the observed differences, as found in the
severely obstructed emphysema patients, it was to be
expected that the nine emphysema patients with less air-
ways obstruction could also be discriminated from the
healthy controls.   In asthma patients in exacerbation
of symptoms  airways obstruction is expected to occur,
with narrowing of peripheral airways, which explains the
lack of difference compared to controls for V25–50.  The
lesser discriminatory power for the V25–75 versus VI rela-
tionship in the case of asthma, may be explained by the
influence of an increased slope of the alveolar plat-
eau on this volume, causing extension of V25–75 into the
alveolar phase.  This same mechanism may explain the
fact that in severely obstructed emphysema patients ver-
sus controls, V25–75 was slightly better than V25–50.
Influence of breathing characteristics, breathing  frequency
and height
The first 10 healthy controls and first 10 severely
obstructed emphysema patients who entered the study,
confirmed that during natural breathing frequency (and
fixed breathing frequencies in the controls) V25–50 and
V25–75 were dependant mainly on VI.  Thus, the dis-
criminatory power of the relationships with VI will not
increase if more breathing characteristics are taken into
account.  Fixed breathing frequency with varying VI
implies higher inspiratory and expiratory flows; where-
as, during natural breathing the respiratory cycle time
increased with increasing VI.  The increase of V25–50 and
V25–75 versus VI with increase of frequency is in agree-
ment with the results in Worth's controls and can be
attributed physiologically to movement of the diffusion
front in a peripheral direction by increased inspiratory
flow, which results in an increased cross diameter of this
front [7, 8].  The increased cross diameter causes an
increase in phase 2 volumes.
WORTH [7, 8] found no relationship between the slopes
of V25–50 and V25–75 versus VI and height in controls.
However, at a fixed inspiratory volume chosen because
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of the volume dependence, we found a significantly pos-
itive correlation of V25–50 and V25–75 with height in the
controls, which is a new finding.  This linear correlation
is certainly based, as for the anatomical dead space [26],
on the relationship with the anatomical dimensions of
the bronchial tree, being body size-dependent.
In conclusion, the results of our study make the use
of phase 2 indices for the diagnosis of emphysema, as
suggested previously [7, 8], doubtful.   Moderately obstruct-
ed emphysema patients could not be distinguished suf-
ficiently from healthy controls, as was the case for the
asthma patients in exacerbation of symptoms versus
severely obstructed emphysema patients if V25–75 was
considered.  Most probably, the explanation of differ-
ences between patient groups, on the basis of serial inho-
mogeneity in a trumpet model of the lung, means an
oversimplification of the complex interaction with par-
allel ventilation perfusion inhomogeneity and asynchro-
nization.
The variables are not sensitive enough for further diag-
nostic application, and certainly the use of more refined
clinical indices for emphysema, as obtained by for instance
a high resolution CT scan, will not influence this con-
clusion.
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